Navigation Links
Operation makes dementia patients faster and smarter
Date:1/25/2011

Researchers from the University of Gothenburg and Sahlgrenska University Hospital are the first in the world to show that an operation can help patients with dementia caused by white matter changes and hydrocephalus.

Presented in the American Journal of Neurosurgery, the results are based on the world's first study to demonstrate the effects of a shunt operation using a placebo control. 14 patients were followed for an average of three and a half years after the operation, with half being given a non-functioning shunt in other words a sham operation and the other half a functioning shunt. This is the equivalent to the placebo given in drug trials to determine how much of the treatment's effect is down to the patient's and others' expectations.

"For obvious reasons, this is problematic in a surgical context and surgical placebo studies are highly unusual," says Magnus Tisell, docent at the Sahlgrenska Academy and consultant neurosurgeon at Sahlgrenska University Hospital. "However, if you can actually do this kind of study, the level of evidence is the highest possible class 1."

The researchers found that patients' mental functions and ability to walk improved tangibly after having a shunt inserted. Half were given an open shunt right from the start and showed immediate improvement, while the other half were initially given a closed shunt and improved only after three months when the shunt was opened.

"Shunt operations have long been used for hydrocephalus, but this study offers more scientifically conclusive results to support the effect of the treatment, and also shows that shunt operations can help far more patients than previously believed with their walking and memory," says Tisell.

Surgery is not generally used today for patients with hydrocephalus and white matter changes. But the researchers' findings pave the way for a brand new group of patients who could benefit from a shunt operation.

"We believe that far more patients than is currently the case could benefit from a shunt operation, which will require more resources," says Tisell. "We also need to find out more about which patients are good candidates for the operation and which shunt is best in each particular case."


'/>"/>

Contact: Magnus Tisell
magnus.tisell@vgregion.se
46-073-400-2029
University of Gothenburg
Source:Eurekalert

Related biology news :

1. Up to 20 million euros for Munich Catalysis research cooperation
2. Cooperation in diabetes research
3. John P. Holdren addresses climate change, stressing need for international cooperation
4. ARS, industry cooperation yields device to detect insects in stored wheat
5. Leading entomologist to give talk at UCR on communication and cooperation in ant societies
6. HFSP President Arima and Secretary General Winnacker awarded for fostering cooperation with China
7. Nanyang Technological University and UK partners heightens cooperation in water industry
8. Negligible impact on public safety from shark cage diving operations
9. Ovarian transplantation: New technique gives greatly improved results in this delicate operation
10. First riser-drilling research operations undertaken
11. Supply Chain Council Partners With APICS The Association for Operations Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2016)... 2016 Securus Technologies, a leading provider of ... investigation, corrections and monitoring, announced today that it has ... have an independent technology judge determine who has the ... tech/sophisticated telephone calling platform, and the best customer service. ... most of what we do – which clearly is ...
(Date:11/15/2016)... 15, 2016  Synthetic Biologics, Inc. (NYSE MKT: ... on the gut microbiome, today announced the pricing ... of its common stock and warrants to purchase ... price to the public of $1.00 per share ... from the offering, excluding the proceeds, if any ...
(Date:6/27/2016)... Research and Markets has announced the addition ... to their offering. The report ... to grow at a CAGR of 12.28% during the period 2016-2020. ... in-depth market analysis with inputs from industry experts. The report covers ... The report also includes a discussion of the key vendors operating ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... Eurofins announces the appointment of Sean Murray , ... Inc. (ESI). Mr. Murray will bring valuable expertise ... experience in leading international business teams. As the National Division Leader, ... uphold Eurofins, status as the global leader in bio-analytical testing services. ... , , ...
(Date:12/8/2016)...  Anaconda BioMed S.L., a pre-clinical stage medical device ... neuro-thrombectomy system for the treatment of Acute Ischemic Stroke ... to join its Scientific Advisory Board (SAB). The SAB ... scientific and clinical experts to Anaconda BioMed S.L., as ... ® to its clinical phase. The SAB is ...
(Date:12/8/2016)... 8, 2016  Soligenix, Inc. (OTCQB: SNGX) (Soligenix ... on developing and commercializing products to treat rare ... announced today the long-term follow-up data from its ... first-in-class Innate Defense Regulator (IDR), in the treatment ... cancer patients undergoing chemoradiation therapy (CRT).  The additional ...
(Date:12/8/2016)... , Dec. 8, 2016  Partnering to fuel ... Ben Franklin Technology Partners of Southeastern Pennsylvania ... ("IHG"), the parent company of Independence Blue Cross; and ... announced their intentions for a $6 million funding initiative ... healthcare startups. Responding to a burgeoning economic ...
Breaking Biology Technology: